ResearchMoz

United States Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and Others

Publisher Name » GlobalData
Published Date » 2011-08-31
No. Of Pages » 501

GlobalDatas new report, United States Cardiovascular Devices Market Outlook to 2017 Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and Others provides key market data on the United States Cardiovascular Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within 10 market categories Cardiac Assist Devices, Cardiac Rhythm Management, Cardiovascular Monitoring and Diagnostic Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery, Electrophysiology, External Defibrillators, Interventional Cardiology, Peripheral Vascular Devices and Prosthetic Heart Valves. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope
  • Market size and company share data for Cardiovascular Devices market categories Cardiac Assist Devices, Cardiac Rhythm Management, Cardiovascular Monitoring and Diagnostic Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery, Electrophysiology, External Defibrillators, Interventional Cardiology, Peripheral Vascular Devices and Prosthetic Heart Valves.
  • Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within 10 market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017. 
  • 2010 company shares and distribution shares data for each of the 10 market categories.
  • Global corporate-level profiles of key companies operating within the United States Cardiovascular Devices market.
  • Key players covered include Medtronic, Inc., Boston Scientific Corporation, St. Jude Medical, Inc., Abbott Laboratories, Cordis Corporation, C. R. Bard, Inc. and others.
Reasons to buy
  • Develop business strategies by identifying the key market categories and segments poised for strong growth.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the United States Cardiovascular Devices competitive landscape.
  • Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and whats the most preferred mode of product distribution Identify, understand and capitalize.
Table of Content

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 What is This Report About?
3 Cardiovascular Devices In United States
3.1 Cardiovascular Devices, United States, Overall Revenue ($m), 2003-2017
3.2 Cardiovascular Devices Market, United States, Revenue Mix ($m), 2010
3.3 Cardiovascular Devices Market, United States, Category Contribution (%), 2010
3.4 Cardiovascular Devices, United States, Category Volume (Units), 2003-2017
3.5 Cardiovascular Devices, United States, Company Share (2009-2010)

4 Cardiac Assist Devices In United States
4.1 Cardiac Assist Devices, Market Segmentation
4.2 Cardiac Assist Devices Market, United States, Revenue Mix ($m), 2010
4.3 Cardiac Assist Devices Market, United States, Segment Contribution (%), 2010
4.4 Cardiac Assist Devices, Overall Revenue (2003-2017)
4.4.1 Intra-Aortic Balloon Pumps Revenue (2003-2017)
4.4.2 Ventricular Assist Devices Revenue (2003-2017)
4.5 Cardiac Assist Devices Overall Volume (2003-2017)
4.5.1 Intra-Aortic Balloon Pumps Volume (2003-2017)
4.5.2 Ventricular Assist Devices Volume (2003-2017)
4.6 Cardiac Assist Devices Average Price (2003-2017)
4.7 Cardiac Assist Devices Distribution Share (2009-2010)
4.8 Cardiac Assist Devices, United States, Company Share (2009-2010)

5 Cardiac Rhythm Management In United States
5.1 Cardiac Rhythm Management, Market Segmentation
5.2 Cardiac Rhythm Management Market, United States, Revenue Mix ($m), 2010
5.3 Cardiac Rhythm Management Market, United States, Segment Contribution (%), 2010
5.4 Cardiac Rhythm Management Overall Revenue (2003-2017)
5.4.1 Cardiac Resynchronisation Therapy Revenue (2003-2017)
5.4.2 Implantable Cardioverter Defibrillators Revenue (2003-2017)
5.4.3 Pacemakers Revenue (2003-2017)
5.5 Cardiac Rhythm Management Overall Volume (2003-2017)
5.5.1 Cardiac Resynchronisation Therapy Volume (2003-2017)
5.5.2 Implantable Cardioverter Defibrillators Volume (2003-2017)
5.5.3 Pacemakers Volume (2003-2017)
5.6 Cardiac Rhythm Management Average Price (2003-2017)
5.7 Cardiac Rhythm Management Distribution Share (2009-2010)
5.8 Cardiac Rhythm Management, United States, Company Share (2009-2010)

6 Cardiovascular Monitoring and Diagnostic Devices In United States
6.1 Cardiovascular Monitoring and Diagnostic Devices, Market Segmentation
6.2 Cardiovascular Monitoring and Diagnostic Devices Market, United States, Revenue Mix ($m), 2010
6.3 Cardiovascular Monitoring and Diagnostic Devices Market, United States, Segment Contribution (%), 2010
6.4 Cardiovascular Monitoring and Diagnostic Devices Overall Revenue (2003-2017)
6.5 Cardiovascular Monitoring and Diagnostic Devices Overall Volume (2003-2017)
6.6 Cardiovascular Monitoring and Diagnostic Devices Average Price (2003-2017)
6.7 Cardiovascular Monitoring and Diagnostic Devices Distribution Share (2009-2010)
6.8 Cardiovascular Monitoring and Diagnostic Devices, United States, Company Share (2009-2010)

7 Cardiovascular Prosthetic Devices In United States
7.1 Cardiovascular Prosthetic Devices, Market Segmentation
7.2 Cardiovascular Prosthetic Devices Market, United States, Revenue Mix ($m), 2010
7.3 Cardiovascular Prosthetic Devices Market, United States, Segment Contribution (%), 2010
7.4 Cardiovascular Prosthetic Devices Overall Revenue (2003-2017)
7.4.1 Septal Occluders Revenue (2003-2017)
7.5 Cardiovascular Prosthetic Devices Overall Volume (2003-2017)
7.5.1 Septal Occluders Volume (2003-2017)
7.6 Cardiovascular Prosthetic Devices Average Price (2003-2017)
7.7 Cardiovascular Prosthetic Devices Distribution Share (2009-2010)
7.8 Cardiovascular Prosthetic Devices, United States, Company Share (2009-2010)

8 Cardiovascular Surgery In United States
8.1 Cardiovascular Surgery, Market Segmentation
8.2 Cardiovascular Surgery Market, United States, Revenue Mix ($m), 2010
8.3 Cardiovascular Surgery Market, United States, Segment Contribution (%), 2010
8.4 Cardiovascular Surgery Overall Revenue (2003-2017)
8.4.1 Beating Heart Surgery Systems Revenue (2003-2017)
8.4.2 Perfusion Disposables Revenue (2003-2017)
8.5 Cardiovascular Surgery Overall Volume (2003-2017)
8.5.1 Beating Heart Surgery Systems Volume (2003-2017)
8.5.2 Perfusion Disposables Volume (2003-2017)
8.6 Cardiovascular Surgery Average Price (2003-2017)
8.7 Cardiovascular Surgery Distribution Share (2009-2010)
8.8 Cardiovascular Surgery, United States, Company Share (2009-2010)

9 Electrophysiology In United States
9.1 Electrophysiology, Market Segmentation
9.2 Electrophysiology Market, United States, Revenue Mix ($m), 2010
9.3 Electrophysiology Market, United States, Segment Contribution (%), 2010
9.4 Electrophysiology Overall Revenue (2003-2017)
9.5 Electrophysiology Overall Volume (2003-2017)
9.6 Electrophysiology Average Price (2003-2017)
9.7 Electrophysiology Distribution Share (2009-2010)
9.8 Electrophysiology, United States, Company Share (2009-2010)

10 External Defibrillators In United States
10.1 External Defibrillators, Market Segmentation
10.2 External Defibrillators Market, United States, Revenue Mix ($m), 2010
10.3 External Defibrillators Market, United States, Segment Contribution (%), 2010
10.4 External Defibrillators Overall Revenue (2003-2017)
10.5 External Defibrillators Overall Volume (2003-2017)
10.6 External Defibrillators Average Price (2003-2017)
10.7 External Defibrillators Distribution Share (2009-2010)
10.8 External Defibrillators, United States, Company Share (2009-2010)

11 Interventional Cardiology In United States
11.1 Interventional Cardiology, Market Segmentation
11.2 Interventional Cardiology Market, United States, Revenue Mix ($m), 2010
11.3 Interventional Cardiology Market, United States, Segment Contribution (%), 2010
11.4 Interventional Cardiology Overall Revenue (2003-2017)
11.4.1 Cardiac Catheters Revenue (2003-2017)
11.4.2 Coronary Stents Revenue (2003-2017)
11.4.3 PTCA Balloons Revenue (2003-2017)
11.4.4 Intravascular Ultrasound Systems (IVUS) Revenue (2003-2017)
11.5 Interventional Cardiology Overall Volume (2003-2017)
11.5.1 Cardiac Catheters Volume (2003-2017)
11.5.2 Coronary Stents Volume (2003-2017)
11.5.3 PTCA Balloons Volume (2003-2017)
11.5.4 Intravascular Ultrasound Systems (IVUS) Volume (2003-2017)
11.6 Interventional Cardiology Average Price (2003-2017)
11.7 Interventional Cardiology Distribution Share (2009-2010)
11.8 Interventional Cardiology, United States, Company Share (2009-2010)
11.8.1 Cardiac Catheters, United States, Company Share (2009-2010)
11.8.2 Coronary Stents, United States, Company Share (2009-2010)

12 Peripheral Vascular Devices In United States
12.1 Peripheral Vascular Devices, Market Segmentation
12.2 Peripheral Vascular Devices Market, United States, Revenue Mix ($m), 2010
12.3 Peripheral Vascular Devices Market, United States, Segment Contribution (%), 2010
12.4 Peripheral Vascular Devices Overall Revenue (2003-2017)
12.4.1 Stent Grafts Revenue (2003-2017)
12.4.2 Inferior Vena Cava Filters (IVCF) Revenue (2003-2017)
12.4.3 Peripheral Vascular Stents Revenue (2003-2017)
12.5 Peripheral Vascular Devices Overall Volume (2003-2017)
12.5.1 Stent Grafts Volume (2003-2017)
12.5.2 Inferior Vena Cava Filters (IVCF) Volume (2003-2017)
12.5.3 Peripheral Vascular Stents Volume (2003-2017)
12.6 Peripheral Vascular Devices Average Price (2003-2017)
12.7 Peripheral Vascular Devices Distribution Share (2009-2010)
12.8 Peripheral Vascular Devices, United States, Company Share (2009-2010)

13 Prosthetic Heart Valves In United States
13.1 Prosthetic Heart Valves, Market Segmentation
13.2 Prosthetic Heart Valves Market, United States, Revenue Mix ($m), 2010
13.3 Prosthetic Heart Valves Market, United States, Segment Contribution (%), 2010
13.4 Prosthetic Heart Valves Overall Revenue (2003-2017)
13.4.1 Mechanical Heart Valves Revenue (2003-2017)
13.4.2 Tissue Heart Valves Revenue (2003-2017)
13.5 Prosthetic Heart Valves Overall Volume (2003-2017)
13.5.1 Mechanical Heart Valves Volume (2003-2017)
13.5.2 Tissue Heart Valves Volume (2003-2017)
13.6 Prosthetic Heart Valves Average Price (2003-2017)
13.7 Prosthetic Heart Valves Distribution Share (2009-2010)
13.8 Prosthetic Heart Valves, United States, Company Share (2009-2010)

14 Overview of Key Companies in United States Cardiovascular Devices Market
14.1 Medtronic, Inc.
14.1.1 Company Overview
14.1.2 Share in the United States Cardiovascular Devices Market
14.2 Boston Scientific Corporation
14.2.1 Company Overview
14.2.2 Share in the United States Cardiovascular Devices Market
14.3 St. Jude Medical, Inc.
14.3.1 Company Overview
14.3.2 Share in the United States Cardiovascular Devices Market
14.4 Abbott Laboratories
14.4.1 Company Overview
14.4.2 Share in the United States Cardiovascular Devices Market
14.5 Cordis Corporation
14.5.1 Company Overview
14.5.2 Share in the United States Cardiovascular Devices Market
14.6 C. R. Bard, Inc.
14.6.1 Company Overview
14.6.2 Share in the United States Cardiovascular Devices Market
14.7 Thoratec Corporation
14.7.1 Company Overview
14.8 Philips Healthcare
14.8.1 Company Overview
14.9 Sorin S.p.A.
14.9.1 Company Overview
14.10 ZOLL Medical Corporation
14.10.1 Company Overview
14.11 MAQUET GmbH & Co. KG
14.11.1 Company Overview
14.12 Edwards Lifesciences Corporation
14.12.1 Company Overview
14.13 Biosense Webster, Inc.
14.13.1 Company Overview
14.14 BIOTRONIK SE & Co. KG
14.14.1 Company Overview
14.15 Terumo Corporation
14.15.1 Company Overview
14.16 Covidien plc
14.16.1 Company Overview
14.17 GE Healthcare
14.17.1 Company Overview
14.18 Volcano Corporation
14.18.1 Company Overview
14.19 Cardiac Science Corporation
14.19.1 Company Overview
14.20 AGA Medical Holdings, Inc.
14.20.1 Company Overview
14.21 Welch Allyn Inc.
14.21.1 Company Overview
14.22 ev3 Inc.
14.22.1 Company Overview
14.23 CareFusion Corporation
14.23.1 Company Overview
14.24 OSI Systems, Inc.
14.24.1 Company Overview
14.25 Mortara Instrument, Inc.
14.25.1 Company Overview
14.26 Card Guard Scientific Survival, Ltd.
14.26.1 Company Overview
14.27 Berlin Heart GmbH
14.27.1 Company Overview
14.28 HeartWare International, Inc.
14.28.1 Company Overview
14.29 Teleflex Incorporated
14.29.1 Company Overview
14.30 Schiller AG
14.30.1 Company Overview
14.31 ABIOMED, Inc.
14.31.1 Company Overview

15 Cardiovascular Devices Market Pipeline Products
15.1 Cardiac Assist Devices Market Pipeline Products
15.1.1 Ventricular Assist Devices Market Pipeline Products
15.1.2 Total Artificial Heart Market Pipeline Products
15.2 Cardiac Rhythm Management Market Pipeline Products
15.2.1 Implantable Cardioverter Defibrillator Market Pipeline Products
15.2.2 Pacemaker Market Pipeline Products
15.2.3 Implantable Cardioverter Defibrillators Market Pipeline Products
15.3 Cardiovascular Monitoring and Diagnostic Devices Market Pipeline Products
15.4 Cardiovascular Prosthetic Devices Market Pipeline Products
15.4.1 Cardiac Valve Repairs Market Pipeline Products
15.4.2 Septal Occluders Market Pipeline Products
15.5 Cardiovascular Surgery Market Pipeline Products
15.6 Electrophysiology Market Pipeline Products
15.6.1 Electrophysiology Ablation Catheters Market Pipeline Products
15.6.2 Electrophysiology Diagnostic Catheters Market Pipeline Products
15.6.3 Electrophysiology Lab Systems Market Pipeline Products
15.7 Interventional Cardiology Market Pipeline Products
15.7.1 Coronary Stents Market Pipeline Products
15.7.2 PTCA Balloon Market Pipeline Products
15.7.3 Cardiac Catheter Market Pipeline Products
15.7.4 Coronary Guidewire Market Pipeline Products
15.7.5 Arteriotomy Closure Devices Market Pipeline Products
15.7.6 PTCA Coronary Drug Eluting Balloons (DEB) Market Pipeline Products
15.7.7 Intravascular Ultrasound Systems (IVUS) Market Pipeline Products
15.8 Peripheral Vascular Devices Market Pipeline Products
15.8.1 Stent Grafts Market Pipeline Products
15.8.2 Peripheral Vascular Stents Market Pipeline Products
15.8.3 PTA Balloons Market Pipeline Products
15.8.4 Synthetic Surgical Grafts Market Pipeline Products
15.8.5 Peripheral Guidewires Market Pipeline Products
15.8.6 Inferior Vena Cava Filters (IVCF) Market Pipeline Products
15.8.7 Peripheral Embolic Protection Devices Market Pipeline Products
15.8.8 PTA Peripheral Drug Eluting Balloons (DEB) Market Pipeline Products
15.9 Prosthetic Heart Valves Market Pipeline Products
15.9.1 Tissue Heart Valves Market Pipeline Products
15.9.2 Mechanical Heart Valves Market Pipeline Products
15.9.3 Transcatheter Heart Valves Market Pipeline Products

16 Financial Deals Landscape
16.1 Acquisition
16.1.1 ValveXchange Receives Equity Investment from CryoLife
16.1.2 Flexible Stenting Solutions Receives Investment From Goodman
16.1.3 St. Jude Medical To Invest In Nanostim
16.1.4 Toshiba Medical Systems Completes Tender Offer To Acquire Vital Images For $273 Million
16.1.5 Baxter International To Acquire Prism Pharmaceuticals
16.1.6 Quest Diagnostics Completes Acquisition Of Celera
16.1.7 Biomedical Structures Acquires Concordia Medical
16.1.8 Veniti to Acquire Varix Medical and Teneo Medical
16.1.9 Physio-Control Acquires Jolife
16.1.10 Medtronic to Sell Physio-Control
16.1.11 Boston Scientific Acquires ReVascular Therapeutics
16.1.12 Cybersonics Acquires Omnisonics Medical Technologies
16.1.13 Boston Scientific Completes Acquisition Of Atritech
16.1.14 Teleflex Acquires VasoNova
16.1.15 Edwards Lifesciences Completes Acquisition Of Embrella Cardiovascular
16.1.16 Medtronic Completes Acquisition Of Remaining Stake In Ardian
16.1.17 Boston Scientific Completes Acquisition Of Remaining Stake In Sadra Medical
16.2 Partnerships
16.2.1 Bioheart Enters Into Licensing Agreement With Airspeed Equity
16.2.2 Vicor Technologies Enters Into Licensing Agreement With ZOLL Medical
16.2.3 NSVascular Enters Into Licensing Agreement With University of California
16.2.4 LiDCO Signs Licensing Agreement With ICU Medical
16.2.5 Aria CV Enters Into Licensing Agreement With University Of Minnesota
16.2.6 Christie Medical Enters Into An Agreement With Eclipse Aesthetics
16.2.7 Luna Innovations Expands Its Licensing Agreement With Hansen Medical
16.2.8 Accumetrics Signs Distribution Agreement With Cardinal Health
16.2.9 Rhythmia Medical Enters Into Joint Development Agreement With Endosense
16.2.10 Acacia Research Enters Into Licensing Agreement With SMITHS MEDICAL ASD
16.2.11 Acacia Research Enters Into Licensing Agreement With Becton, Dickinson And Argon Medical
16.2.12 International Cardio Enters Into Licensing Agreement With University of Minnesota
16.2.13 Boston Scientific Enters Into Partnership With Greatbatch Medical
16.2.14 American Hospital Management Enters Into Joint Venture Agreement With Royal St. Kitts Beach Resort
16.2.15 Physio-Control Enters Into Strategic Partnership With BeneChill
16.2.16 APICA Cardiovascular Enters Into Licensing Agreement With Georgia Institute And Emory University

17 Recent Developments
17.1 Strategy and Business Planning
17.1.1 Jul 29, 2011: WorldHeart to End Levacor VAD Program
17.1.2 Jun 27, 2011: Cook Medical Expands Asia-Pacific Distribution Centre In China To Meet Regional Surge In Growth Of Medical Device Market
17.1.3 Jun 15, 2011: Cordis Announces Discontinuation Of NEVO Sirolimus-Eluting Coronary Stent
17.1.4 May 20, 2011: LeMaitre To Consolidate California Factory
17.1.5 May 09, 2011: Cook Expands Raw Materials Manufacturing To Canton, Illinois
17.1.6 May 05, 2011: Medtronic Opens New Distribution Center In Mira Loma, California
17.1.7 Mar 08, 2011: Medtronic Inaugurates New Regional Headquarters Building In Greater China
17.1.8 Feb 10, 2011: C. R. Bard To Reduce Workforce By 20%
17.1.9 Feb 10, 2011: J&J Cordis Reduces Workforce In US
17.1.10 Jan 27, 2011: Greatbatch Medical To Build New Facility In Fort Wayne
17.1.11 Jan 10, 2011: Vasomedical Launches Online Store
17.1.12 Dec 13, 2010: Bard To Improve Overall Cost Structure And Enhance Operational Effectiveness
17.1.13 Nov 30, 2010: Hansen Opens European Commercialization And Training Center
17.1.14 Nov 09, 2010: Medtronic Opens New Distribution Center In Elizabeth, New Jersey
17.1.15 Oct 21, 2010: Collagen Matrix Expands Operations And Moves Corporate Headquarters To Oakland, New Jersey
17.1.16 Oct 14, 2010: SurModics Announces Organizational Changes To Reduce Cost Structure And Renew Focus On Business Units
17.1.17 Oct 07, 2010: AT&T, eCardio Team Up To Advance Cardiac Care Through Innovative Mobile Technology
17.1.18 Oct 04, 2010: Edwards Lifesciences Opens New Facility In Utah
17.1.19 Sep 29, 2010: Edwards Lifesciences To Open New Manufacturing Facility In Utah
17.1.20 Sep 24, 2010: Merit Medical To Commence Construction Of New Building On South Jordan Campus
17.1.21 Aug 19, 2010: Boston Scientific To Invest In New Products: CEO
17.1.22 Aug 16, 2010: Orchid Expands Cleaning And Packaging Capabilities In Southfield, Michigan
17.1.23 Aug 09, 2010: Orthofix To Open New North American Operations And Education Center In Texas
17.2 Legal and Regulatory
17.2.1 Jul 12, 2011: Acacia Subsidiary Enters Into Settlement Agreement With Boston Scientific
17.2.2 Jun 07, 2011: Boston Scientific Gets Favorable Court Ruling Affirming Invalidity Of J&J Patents
17.2.3 May 24, 2011: Jensen Law Firm Announces $10m Verdict Against Johnson & Johnson Unit For Toxic Motrin Reaction
17.2.4 May 11, 2011: Boston Scientific Announces Favorable Jury Verdict Against Cordis In Stent Patent Litigation
17.2.5 May 03, 2011: U.S. Senate Finance Committee Announces Investigation Against Medtronic
17.2.6 Apr 27, 2011: Acacia Subsidiary Enters Into Settlement Agreement With Cordis
17.2.7 Apr 25, 2011: St. Jude Medical Wins $2.3 Billion In Trade Secret Infringement Lawsuit Against Nervicon
17.2.8 Apr 07, 2011: J&J To Pay $70m To Settle Cases Brought By SEC And Criminal Authorities
17.2.9 Feb 08, 2011: Medtronic Issues Statement On District Court Ruling Regarding CoreValve
17.2.10 Feb 08, 2011: Edwards Lifesciences Issues Statment Regarding US Court Ruling
17.2.11 Jan 28, 2011: Boston Scientific Responds To DOJ Civil Lawsuit
17.2.12 Jan 28, 2011: Federal Jury In Marshall, Texas Returns $482 Million Verdict For Dickstein Shapiro Client
17.2.13 Jan 27, 2011: US Files Suit Against Guidant And Boston Scientific For Selling Defective Heart Devices That Were Implanted In Medicare Patients
17.2.14 Jan 20, 2011: St. Jude Medical Reaches Settlement With DOJ
17.2.15 Jan 12, 2011: Guidant To Pay Criminal Penalty Of More Than $296 Million And Three Years Probation
17.2.16 Jan 11, 2011: Boston Scientific Reaches Settlement With Medinol
17.2.17 Jan 07, 2011: Judge Dismisses Class Action Lawsuit Against Medtronic Over Product Problem Issues
17.2.18 Dec 09, 2010: VNUS Reports Jury Returns Verdict In VNUS' Lawsuit With TVS And biolitec
17.2.19 Nov 10, 2010: St. Jude Medical And AGA Medical Announce Early Termination Of HSR Waiting Period
17.2.20 Nov 02, 2010: CSI Settles Employee Lawsuit With ev3
17.2.21 Nov 01, 2010: Ela Medical To Pay $9.2 Million To Resolve Kickbacks Claims
17.2.22 Nov 01, 2010: AGA Medical Investor Files Lawsuit Against Buyout
17.2.23 Oct 22, 2010: Sorin Announces Full And Final Settlement Of Investigation By DOJ
17.2.24 Oct 19, 2010: Howard G. Smith Investigates Proposed Acquisition Of Cardiac Science By OCI
17.2.25 Oct 18, 2010: Robbins Umeda Investigates Acquisition Of AGA Medical By St. Jude Medical
17.2.26 Oct 14, 2010: Medtronic Settles US Lawsuits On Sprint Fidelis Family Of Defibrillation Leads
17.2.27 Oct 04, 2010: Guide Flow Sues Six Companies Over Catheter Patent
17.2.28 Oct 04, 2010: Wall Cardiovascular Settles With Medtronic, Boston Scientific Over Stent Patent
17.2.29 Sep 28, 2010: Boston Scientific Urges Federal Court To Dismiss Guidant Lawsuit
17.2.30 Sep 23, 2010: St. Jude Medical Faces Derivative Suit From Shareholders
17.2.31 Sep 22, 2010: AIC Must Pay Out On $50 Million Policy In St. Jude Medical’s Silzone Case
17.2.32 Sep 20, 2010: Volcano Files Counterclaim Asserting St. Jude Infringes Three Patents
17.2.33 Sep 20, 2010: ConMed Files Complaint Against Former Sales Consultant
17.2.34 Sep 16, 2010: Minnesota Appeals Court Denies Appeal Of Medtronic Sprint Fidelis Case
17.2.35 Aug 26, 2010: St. Jude Medical In Talks With DOJ Kickbacks Case
17.2.36 Aug 24, 2010: AGA Medical Sues W.L. Gore & Associates For Patent Infringement
17.2.37 Aug 24, 2010: AtriCure might Resolve Class Action Lawsuit For $2.8 Million
17.2.38 Aug 18, 2010: Atrium Responds To Bard Suit
17.2.39 Aug 11, 2010: CardioNet Provides Update On Class Action Litigation
17.2.40 Aug 11, 2010: Endologix Responds To Patent Infringement Disputes With Bard Peripheral
17.3 Government and Public Interest
17.3.1 Jul 18, 2011: BG Medicine Receives ISO 13485 Certification
17.3.2 Jul 13, 2011: New Method Defibrillates Heart With Less Electricity, Pain: Cornell University
17.3.3 Jul 11, 2011: Mayo Clinic's VAD Program Offers Hope For Heart Failure Patients
17.3.4 Jul 10, 2011: MGH Researchers Develop One-Micrometer-Resolution Version Of Intravascular Imaging Technology
17.3.5 Jun 29, 2011: Hospira Supports North Carolina's New Legislation Aimed At Reducing Healthcare-Associated Infections
17.3.6 Jun 28, 2011: New Study Shows Viability Of Heart Pumps For Older Heart-Failure Patients
17.3.7 Jun 27, 2011: Boston Scientific Applauds Passage Of Patent Reform Bill
17.3.8 Jun 24, 2011: Hospitals, Healthcare Providers To Benefit From New Premier Agreements For Invasive Hemodynamic Monitoring Products And Accessories
17.3.9 Jun 21, 2011: Spaulding Clinical Quality Management System Achieves ISO 13485 Certification
17.3.10 Jun 20, 2011: Teleflex Resolves FDA Corporate Warning Letter
17.3.11 Jun 14, 2011: FDA Recalls Boston Scientific's Atlantis SR Pro2 Coronary Imaging Catheters In Addition To iCross Catheters
17.3.12 Jun 13, 2011: Echocardiography Shows Promise In Guiding Gene Therapy For Disease Prevention And Treatment
17.3.13 May 26, 2011: Drug-Eluting Stents Using Biodegradable Polymer Significantly Improve Overall Clinical Outcomes
17.3.14 May 06, 2011: Study Shows Stents Are Superior To Balloons Alone For Patients With Deep Venous Thrombosis
17.3.15 May 05, 2011: SCAI Releases First Report On Transradial Access For Angioplasty And Stenting
17.3.16 May 05, 2011: HERCULES Trial Demonstrates Significant Reduction In Systolic Blood Pressure While Revealing Marker In Hypertensive Patients Does Not Predict Outcomes Of Renal Artery Stenting
17.3.17 May 05, 2011: Specialized Signals Inside ICDs Provide Ongoing Monitoring For High-Risk Patients: Study
17.3.18 May 03, 2011: Premier, BIOTRONIK To Offer Savings Opportunities For CRM Devices
17.3.19 Apr 29, 2011: Defibtech Announces Voluntary Recall Of DDU-100 Series AEDs
17.3.20 Apr 27, 2011: CareCore National Recommends Adoption of Prior Authorization to Improve Patient Outcomes And Curb Healthcare Spend
17.3.21 Apr 16, 2011: New Patient Guidelines for Heart Devices Presented At International Society Of Heart And Lung Transplantation Annual Meeting
17.3.22 Apr 14, 2011: Progress In Development Of Mechanical Circulatory Support Devices For Children To Be Presented At ISHLT Annual Meeting
17.3.23 Apr 14, 2011: St Jude Medical Receives FDA And CE Mark Approvals For ShockGuard Technology
17.3.24 Apr 11, 2011: Philips Medical Systems Receives Amended Warning Letter From FDA
17.3.25 Apr 03, 2011: New Study Shows Aortic Valve Replacement Via Catheter Produces Better Outcomes Than Traditional Open-Heart Surgery
17.3.26 Mar 23, 2011: Mayo Clinic Researchers Find Cardiac Pacing Helps Epilepsy Patients With Ictal Asystole
17.3.27 Mar 22, 2011: Terumo Cardiovascular Systems Reaches Agreement on Terms of Consent Decree with FDA Regarding Quality System Improvements
17.3.28 Mar 21, 2011: Millar Instruments Issues Recall Of Millar Mikro-Tip Angiographic Catheter, Model SPC-454D And SPC-454F
17.3.29 Mar 14, 2011: Winthrop-University Hospital Implants Revo MRI Surescan Pacing System
17.3.30 Mar 09, 2011: Medtronic Resolves FDA Warning Letters
17.3.31 Mar 03, 2011: Analysis Of SAPPHIRE Data In March Issue Of CCI Supports CAS As Cost-Effective Alternative To CEA
17.3.32 Mar 01, 2011: Women Get Short Shrift In Many Heart Device Studies, Despite Requirement: Study
17.3.33 Feb 03, 2011: Abiomed Announces Survey Results And Launches National Heart Recovery Awareness Campaign
17.3.34 Jan 26, 2011: Texas Heart Institute At St. Luke’s Episcopal Hospital First In Texas To Offer New Cardiology Procedure To Eliminate A Major Cause Of Heart-Related Stroke
17.3.35 Jan 25, 2011: Occurrence Of Stroke After CABG Surgery Appears To Be Decreasing: Study
17.3.36 Jan 24, 2011: University Of Michigan, University Of Pittsburgh To Lead REVIVE-IT Study With $13.3 Million In Support From NHLBI, HeartWare
17.3.37 Jan 21, 2011: FDA To Implement Stricter Approval Process For Defibrillators
17.3.38 Jan 20, 2011: Spectranetics Receives FDA Approval For Site Change Related To Manufacturing Of CVX-300 Laser System
17.3.39 Jan 19, 2011: SCAI Publishes Radiation Safety Program Principles For Cardiac Catheterization Labs
17.3.40 Jan 04, 2011: Many Patients With ICDs Do Not Meet Criteria For Use: JAMA Study
17.4 Product News
17.4.1 Jul 13, 2011: Toshiba Installs Infinix CF-i Bi-Plane System With CAT-880B Hybrid Catheterization Table At Arnold Palmer Hospital for Children In Orlando, Florida
17.4.2 Jul 12, 2011: Boston Scientific Completes Clinical Trial Enrollment For Adapt Monorail Carotid Stent System
17.4.3 Jan 21, 2011: Cardiac Science Extends Device Connectivity To Allscripts Professional Electronic Health Record
17.4.4 Oct 26, 2010: eCardio Plans To Streamline Products
17.4.5 Sep 10, 2010: CorMatrix Receives FDA IDE Approval To Begin Clinical Evaluation Of New Onset Postoperative Atrial Fibrillation In Subjects Receiving CorMatrix ECM For Pericardial Closure
17.4.6 Sep 01, 2010: ZOLL To Showcase LifeVest Wearable Defibrillator At The Heart Failure Society Of America Annual Meeting
17.4.7 Aug 04, 2010: Beaumont Hospital Physicians Screens High School Students Using GE Healthcare’s MAC 800 ECG
17.4.8 Jul 20, 2010: Spectranetics Announces Reimbursement Approval For Laser-Assisted Lead Extraction In Japan
17.4.9 Jul 12, 2010: BIOTRONIK Unveils Final Results Of TRUST Trial For BIOTRONIK Home Monitoring

18 Appendix
18.1 Definitions of Markets Covered in the Report
18.1.1 Cardiovascular Devices
18.2 Secondary Research
18.3 Primary Research
18.4 Models
18.5 Forecasts
18.6 Expert Panels
18.7 GlobalData Consulting
18.8 Currency Conversion
18.9 Contact Us
18.10 Disclaimer

List of Tables


Table 1: Cardiovascular Devices, United States, Overall Revenue ($m), 2003-2017 31
Table 2: Cardiovascular Devices Market, United States, Category Contribution (%), 2010 33
Table 3: Cardiovascular Devices, United States, Cross-Category Analysis, 2003-2017 35
Table 4: Cardiovascular Devices, United States, Overall Revenue ($m), Historic, 2003-2010 37
Table 5: Cardiovascular Devices, United States, Overall Revenue ($m), Forecast, 2010-2017 39
Table 6: Cardiovascular Devices, United States, Category Volume (Units), 2003-2017 41
Table 7: Cardiovascular Devices, United States, Category Volume (Units), Historic, 2003-2010 43
Table 8: Cardiovascular Devices, United States, Category Volume (Units), Forecast, 2010-2017 45
Table 9: Cardiovascular Devices, United States, Company Share by Revenue ($m), 2009-2010 47
Table 10: Cardiac Assist Devices Market, United States, Segment Contribution (%), 2010 50
Table 11: Cardiac Assist Devices, United States, Revenue ($m) by Segment, Historic, 2003-2010 52
Table 12: Cardiac Assist Devices, United States, Revenue ($m) by Segment, Forecast, 2010-2017 54
Table 13: Intra-Aortic Balloon Pumps, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 56
Table 14: Intra-Aortic Balloon Pumps, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 58
Table 15: Ventricular Assist Devices, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 60
Table 16: Ventricular Assist Devices, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 62
Table 17: Cardiac Assist Devices, United States, Volume (Units) by Segment, Historic, 2003-2010 64
Table 18: Cardiac Assist Devices, United States, Volume (Units) by Segment, Forecast, 2010-2017 66
Table 19: Intra-Aortic Balloon Pumps, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 68
Table 20: Intra-Aortic Balloon Pumps, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 70
Table 21: Ventricular Assist Devices, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 72
Table 22: Ventricular Assist Devices, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 74
Table 23: Cardiac Assist Devices, United States, Average Price ($), Historic, 2003-2010 75
Table 24: Cardiac Assist Devices, United States, Average Price ($), Forecast, 2010-2017 76
Table 25: Cardiac Assist Devices, United States, Distribution Share by Revenue ($m), 2009-2010 77
Table 26: Cardiac Assist Devices, United States, Company Share by Revenue ($m), 2009-2010 79
Table 27: Cardiac Rhythm Management Market, United States, Segment Contribution (%), 2010 82
Table 28: Cardiac Rhythm Management, United States, Revenue ($m) by Segment, Historic, 2003-2010 84
Table 29: Cardiac Rhythm Management, United States, Revenue ($m) by Segment, Forecast, 2010-2017 86
Table 30: Cardiac Resynchronisation Therapy, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 88
Table 31: Cardiac Resynchronisation Therapy, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 90
Table 32: Implantable Cardioverter Defibrillators, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 92
Table 33: Implantable Cardioverter Defibrillators, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 94
Table 34: Pacemakers, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 96
Table 35: Pacemakers, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 98
Table 36: Cardiac Rhythm Management, United States, Volume (Units) by Segment, Historic, 2003-2010 100
Table 37: Cardiac Rhythm Management, United States, Volume (Units) by Segment, Forecast, 2010-2017 102
Table 38: Cardiac Resynchronisation Therapy, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 104
Table 39: Cardiac Resynchronisation Therapy, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 106
Table 40: Implantable Cardioverter Defibrillators, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 108
Table 41: Implantable Cardioverter Defibrillators, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 110
Table 42: Pacemakers, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 112
Table 43: Pacemakers, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 113
Table 44: Cardiac Rhythm Management, United States, Average Price ($), Historic, 2003-2010 114
Table 45: Cardiac Rhythm Management, United States, Average Price ($), Forecast, 2010-2017 114
Table 46: Cardiac Rhythm Management, United States, Distribution Share by Revenue ($m), 2009-2010 115
Table 47: Cardiac Rhythm Management, United States, Company Share by Revenue ($m), 2009-2010 117
Table 48: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Segment Contribution (%), 2010 120
Table 49: Cardiovascular Monitoring and Diagnostic Devices, United States, Revenue ($m) by Segment, Historic, 2003-2010 122
Table 50: Cardiovascular Monitoring and Diagnostic Devices, United States, Revenue ($m) by Segment, Forecast, 2010-2017 124
Table 51: Cardiovascular Monitoring and Diagnostic Devices, United States, Volume (Units) by Segment, Historic, 2003-2010 126
Table 52: Cardiovascular Monitoring and Diagnostic Devices, United States, Volume (Units) by Segment, Forecast, 2010-2017 128
Table 53: Cardiovascular Monitoring and Diagnostic Devices, United States, Average Price ($), Historic, 2003-2010 129
Table 54: Cardiovascular Monitoring and Diagnostic Devices, United States, Average Price ($), Forecast, 2010-2017 130
Table 55: Cardiovascular Monitoring and Diagnostic Devices, United States, Distribution Share by Revenue ($m), 2009-2010 131
Table 56: Cardiovascular Monitoring and Diagnostic Devices, United States, Company Share by Revenue ($m), 2009-2010 133
Table 57: Cardiovascular Prosthetic Devices Market, United States, Segment Contribution (%), 2010 136
Table 58: Cardiovascular Prosthetic Devices, United States, Revenue ($m) by Segment, Historic, 2003-2010 138
Table 59: Cardiovascular Prosthetic Devices, United States, Revenue ($m) by Segment, Forecast, 2010-2017 140
Table 60: Septal Occluders, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 142
Table 61: Septal Occluders, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 144
Table 62: Cardiovascular Prosthetic Devices, United States, Volume (Units) by Segment, Historic, 2003-2010 146
Table 63: Cardiovascular Prosthetic Devices, United States, Volume (Units) by Segment, Forecast, 2010-2017 148
Table 64: Septal Occluders, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 150
Table 65: Septal Occluders, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 152
Table 66: Cardiovascular Prosthetic Devices, United States, Average Price ($), Historic, 2003-2010 153
Table 67: Cardiovascular Prosthetic Devices, United States, Average Price ($), Forecast, 2010-2017 153
Table 68: Cardiovascular Prosthetic Devices, United States, Distribution Share by Revenue ($m), 2009-2010 154
Table 69: Cardiovascular Prosthetic Devices, United States, Company Share by Revenue ($m), 2009-2010 156
Table 70: Cardiovascular Surgery Market, United States, Segment Contribution (%), 2010 159
Table 71: Cardiovascular Surgery, United States, Revenue ($m) by Segment, Historic, 2003-2010 161
Table 72: Cardiovascular Surgery, United States, Revenue ($m) by Segment, Forecast, 2010-2017 163
Table 73: Beating Heart Surgery Systems, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 165
Table 74: Beating Heart Surgery Systems, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 167
Table 75: Perfusion Disposables, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 169
Table 76: Perfusion Disposables, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 171
Table 77: Cardiovascular Surgery, United States, Volume (Units) by Segment, Historic, 2003-2010 173
Table 78: Cardiovascular Surgery, United States, Volume (Units) by Segment, Forecast, 2010-2017 175
Table 79: Beating Heart Surgery Systems, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 177
Table 80: Beating Heart Surgery Systems, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 179
Table 81: Perfusion Disposables, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 181
Table 82: Perfusion Disposables, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 183
Table 83: Cardiovascular Surgery, United States, Average Price ($), Historic, 2003-2010 184
Table 84: Cardiovascular Surgery, United States, Average Price ($), Forecast, 2010-2017 184
Table 85: Cardiovascular Surgery, United States, Distribution Share by Revenue ($m), 2009-2010 185
Table 86: Cardiovascular Surgery, United States, Company Share by Revenue ($m), 2009-2010 187
Table 87: Electrophysiology Market, United States, Segment Contribution (%), 2010 190
Table 88: Electrophysiology, United States, Revenue ($m) by Segment, Historic, 2003-2010 192
Table 89: Electrophysiology, United States, Revenue ($m) by Segment, Forecast, 2010-2017 194
Table 90: Electrophysiology, United States, Volume (Units) by Segment, Historic, 2003-2010 196
Table 91: Electrophysiology, United States, Volume (Units) by Segment, Forecast, 2010-2017 198
Table 92: Electrophysiology, United States, Average Price ($), Historic, 2003-2010 199
Table 93: Electrophysiology, United States, Average Price ($), Forecast, 2010-2017 199
Table 94: Electrophysiology, United States, Distribution Share by Revenue ($m), 2009-2010 200
Table 95: Electrophysiology, United States, Company Share by Revenue ($m), 2009-2010 202
Table 96: External Defibrillators Market, United States, Segment Contribution (%), 2010 205
Table 97: External Defibrillators, United States, Revenue ($m) by Segment, Historic, 2003-2010 207
Table 98: External Defibrillators, United States, Revenue ($m) by Segment, Forecast, 2010-2017 209
Table 99: External Defibrillators, United States, Volume (Units) by Segment, Historic, 2003-2010 211
Table 100: External Defibrillators, United States, Volume (Units) by Segment, Forecast, 2010-2017 213
Table 101: External Defibrillators, United States, Average Price ($), Historic, 2003-2010 214
Table 102: External Defibrillators, United States, Average Price ($), Forecast, 2010-2017 214
Table 103: External Defibrillators, United States, Distribution Share by Revenue ($m), 2009-2010 215
Table 104: External Defibrillators, United States, Company Share by Revenue ($m), 2009-2010 216
Table 105: Interventional Cardiology Market, United States, Segment Contribution (%), 2010 219
Table 106: Interventional Cardiology, United States, Revenue ($m) by Segment, Historic, 2003-2010 221
Table 107: Interventional Cardiology, United States, Revenue ($m) by Segment, Forecast, 2010-2017 223
Table 108: Cardiac Catheters, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 225
Table 109: Cardiac Catheters, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 227
Table 110: Coronary Stents, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 229
Table 111: Coronary Stents, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 231
Table 112: PTCA Balloons, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 233
Table 113: PTCA Balloons, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 235
Table 114: Intravascular Ultrasound Systems (IVUS), United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 237
Table 115: Intravascular Ultrasound Systems (IVUS), United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 239
Table 116: Interventional Cardiology, United States, Volume (Units) by Segment, Historic, 2003-2010 241
Table 117: Interventional Cardiology, United States, Volume (Units) by Segment, Forecast, 2010-2017 243
Table 118: Cardiac Catheters, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 245
Table 119: Cardiac Catheters, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 246
Table 120: Coronary Stents, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 248
Table 121: Coronary Stents, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 249
Table 122: PTCA Balloons, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 251
Table 123: PTCA Balloons, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 253
Table 124: Intravascular Ultrasound Systems (IVUS), United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 255
Table 125: Intravascular Ultrasound Systems (IVUS), United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 257
Table 126: Interventional Cardiology, United States, Average Price ($), Historic, 2003-2010 258
Table 127: Interventional Cardiology, United States, Average Price ($), Forecast, 2010-2017 259
Table 128: Interventional Cardiology, United States, Distribution Share by Revenue ($m), 2009-2010 260
Table 129: Interventional Cardiology, United States, Company Share by Revenue ($m), 2009-2010 262
Table 130: Cardiac Catheters, United States, Company Share by Revenue ($m), 2009-2010 263
Table 131: Coronary Stents, United States, Company Share by Revenue ($m), 2009-2010 264
Table 132: Peripheral Vascular Devices Market, United States, Segment Contribution (%), 2010 267
Table 133: Peripheral Vascular Devices, United States, Revenue ($m) by Segment, Historic, 2003-2010 269
Table 134: Peripheral Vascular Devices, United States, Revenue ($m) by Segment, Forecast, 2010-2017 271
Table 135: Stent Grafts, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 273
Table 136: Stent Grafts, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 275
Table 137: Inferior Vena Cava Filters (IVCF), United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 277
Table 138: Inferior Vena Cava Filters (IVCF), United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 279
Table 139: Peripheral Vascular Stents, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 281
Table 140: Peripheral Vascular Stents, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 283
Table 141: Peripheral Vascular Devices, United States, Volume (Units) by Segment, Historic, 2003-2010 285
Table 142: Peripheral Vascular Devices, United States, Volume (Units) by Segment, Forecast, 2010-2017 287
Table 143: Stent Grafts, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 289
Table 144: Stent Grafts, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 290
Table 145: Inferior Vena Cava Filters (IVCF), United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 292
Table 146: Inferior Vena Cava Filters (IVCF), United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 294
Table 147: Peripheral Vascular Stents, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 296
Table 148: Peripheral Vascular Stents, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 298
Table 149: Peripheral Vascular Devices, United States, Average Price ($), Historic, 2003-2010 299
Table 150: Peripheral Vascular Devices, United States, Average Price ($), Forecast, 2010-2017 300
Table 151: Peripheral Vascular Devices, United States, Distribution Share by Revenue ($m), 2009-2010 301
Table 152: Peripheral Vascular Devices, United States, Company Share by Revenue ($m), 2009-2010 303
Table 153: Prosthetic Heart Valves Market, United States, Segment Contribution (%), 2010 306
Table 154: Prosthetic Heart Valves, United States, Revenue ($m) by Segment, Historic, 2003-2010 308
Table 155: Prosthetic Heart Valves, United States, Revenue ($m) by Segment, Forecast, 2010-2017 309
Table 156: Mechanical Heart Valves, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 311
Table 157: Mechanical Heart Valves, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 313
Table 158: Tissue Heart Valves, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 315
Table 159: Tissue Heart Valves, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 317
Table 160: Prosthetic Heart Valves, United States, Volume (Units) by Segment, Historic, 2003-2010 318
Table 161: Prosthetic Heart Valves, United States, Volume (Units) by Segment, Forecast, 2010-2017 319
Table 162: Mechanical Heart Valves, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 321
Table 163: Mechanical Heart Valves, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 323
Table 164: Tissue Heart Valves, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 325
Table 165: Tissue Heart Valves, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 327
Table 166: Prosthetic Heart Valves, United States, Average Price ($), Historic, 2003-2010 328
Table 167: Prosthetic Heart Valves, United States, Average Price ($), Forecast, 2010-2017 328
Table 168: Prosthetic Heart Valves, United States, Distribution Share by Revenue ($m), 2009-2010 329
Table 169: Prosthetic Heart Valves, United States, Company Share by Revenue ($m), 2009-2010 331
Table 170: Ventricular Assist Devices Market Pipeline Products 347
Table 171: Total Artificial Heart Market Pipeline Products 348
Table 172: Implantable Cardioverter Defibrillator Market Pipeline Products 349
Table 173: Pacemaker Market Pipeline Products 350
Table 174: Implantable Cardioverter Defibrillators Market Pipeline Products 351
Table 175: Cardiovascular Monitoring and Diagnostic Devices Market Pipeline Products 352
Table 176: Cardiac Valve Repairs Market Pipeline Products 355
Table 177: Septal Occluders Market Pipeline Products 356
Table 178: Cardiovascular Surgery Market Pipeline Products 357
Table 179: Electrophysiology Ablation Catheters Market Pipeline Products 359
Table 180: Electrophysiology Diagnostic Catheters Market Pipeline Products 361
Table 181: Electrophysiology Lab Systems Market Pipeline Products 361
Table 182: Ventricular Assist Devices Market Pipeline Products 362
Table 183: Bare Metal Stents Market Pipeline Products 365
Table 184: PTCA Balloon Market Pipeline Products 366
Table 185: Cardiac Catheter Market Pipeline Products 367
Table 186: Coronary Guidewire Market Pipeline Products 368
Table 187: Arteriotomy Closure Devices Market Pipeline Products 368
Table 188: PTCA Coronary Drug Eluting Balloons Market Pipeline Products 369
Table 189: Intravascular Ultrasound Systems (IVUS) Market Pipeline Products 370
Table 190: Stent Grafts Market Pipeline Products 371
Table 191: Peripheral Vascular Stents Market Pipeline Products 373
Table 192: PTA Balloons Market Pipeline Products 375
Table 193: Synthetic Surgical Grafts Market Pipeline Products 376
Table 194: Peripheral Guidewires Market Pipeline Products 376
Table 195: Inferior Vena Cava Filters (IVCF)Market Pipeline Products 377
Table 196: Peripheral Embolic Protection Devices Market Pipeline Products 378
Table 197: PTA Peripheral Drug Eluting Balloons (DEB) Market Pipeline Products 379
Table 198: Tissue Heart Valves Market Pipeline Products 380
Table 199: Mechanical Heart Valves Market Pipeline Products 381
Table 200: Transcatheter Heart Valves Market Pipeline Products 382
Table 201: ValveXchange Receives Equity Investment From CryoLife 383
Table 202: Flexible Stenting Solutions Receives Investment From Goodman 385
Table 203: St. Jude Medical To Invest In Nanostim 386
Table 204: Toshiba Medical Systems Completes Tender Offer To Acquire Vital Images For $273 Million 387
Table 205: Baxter International To Acquire Prism Pharmaceuticals 389
Table 206: Quest Diagnostics Completes Acquisition Of Celera 391
Table 207: Biomedical Structures Acquires Concordia Medical 394
Table 208: Veniti To Acquire Varix Medical And Teneo Medical 395
Table 209: Physio-Control Acquires Jolife 396
Table 210: Medtronic To Sell Physio-Control 398
Table 211: Boston Scientific Acquires ReVascular Therapeutics 399
Table 212: Cybersonics Acquires Omnisonics Medical Technologies 400
Table 213: Boston Scientific Completes Acquisition Of Atritech 401
Table 214: Teleflex Acquires VasoNova 404
Table 215: Edwards Lifesciences Completes Acquisition Of Embrella Cardiovascular 406
Table 216: Medtronic Completes Acquisition Of Remaining Stake In Ardian 408
Table 217: Boston Scientific Completes Acquisition Of Remaining Stake In Sadra Medical 410
Table 218: Bioheart Enters Into Licensing Agreement With Airspeed Equity 413
Table 219: Vicor Technologies Enters Into Licensing Agreement With ZOLL Medical 414
Table 220: NSVascular Enters Into Licensing Agreement With University of California 415
Table 221: LiDCO Signs Licensing Agreement With ICU Medical 416
Table 222: Aria CV Enters Into Licensing Agreement With University Of Minnesota 417
Table 223: Christie Medical Enters Into An Agreement With Eclipse Aesthetics 418
Table 224: Luna Innovations Expands Its Licensing Agreement With Hansen Medical 419
Table 225: Accumetrics Signs Distribution Agreement With Cardinal Health 420
Table 226: Rhythmia Medical Enters Into Joint Development Agreement With Endosense 421
Table 227: Acacia Research Enters Into Licensing Agreement With SMITHS MEDICAL ASD 422
Table 228: Acacia Research Enters Into Licensing Agreement With Becton, Dickinson And Argon Medical 423
Table 229: International Cardio Enters Into Licensing Agreement With University of Minnesota 424
Table 230: Boston Scientific Enters Into Partnership With Greatbatch Medical 425
Table 231: American Hospital Management Enters Into Joint Venture Agreement With Royal St. Kitts Beach Resort 426
Table 232: Physio-Control Enters Into Strategic Partnership With BeneChill 427
Table 233: APICA Cardiovascular Enters Into Licensing Agreement With Georgia Institute And Emory University 428
Table 234: USD to Local Currency, United States, Average Actual Rate 2003-2010 501

List of Figures


Figure 1: Cardiovascular Devices, United States, Overall Revenue ($m), 2003-2017 30
Figure 2: Cardiovascular Devices Market, United States, Revenue Mix ($m), 2010 32
Figure 3: Cardiovascular Devices Market, United States, Category Contribution (%), 2010 33
Figure 4: Cardiovascular Devices, United States, Cross-Category Analysis, 2003-2017 34
Figure 5: Cardiovascular Devices, United States, Overall Revenue ($m), Historic, 2003-2010 36
Figure 6: Cardiovascular Devices, United States, Overall Revenue ($m), Forecast, 2010-2017 38
Figure 7: Cardiovascular Devices, United States, Category Volume (Units), 2003-2017 40
Figure 8: Cardiovascular Devices, United States, Category Volume (Units), Historic, 2003-2010 42
Figure 9: Cardiovascular Devices, United States, Category Volume (Units), Forecast, 2010-2017 44
Figure 10: Cardiovascular Devices, United States, Company Share (%), 2010 46
Figure 11: Cardiac Assist Devices, Market Segmentation 48
Figure 12: Cardiac Assist Devices Market, United States, Revenue Mix ($m), 2010 49
Figure 13: Cardiac Assist Devices Market, United States, Segment Contribution (%), 2010 50
Figure 14: Cardiac Assist Devices, United States, Revenue ($m) by Segment, Historic, 2003-2010 51
Figure 15: Cardiac Assist Devices, United States, Revenue ($m) by Segment, Forecast, 2010-2017 53
Figure 16: Intra-Aortic Balloon Pumps, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 55
Figure 17: Intra-Aortic Balloon Pumps, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 57
Figure 18: Ventricular Assist Devices, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 59
Figure 19: Ventricular Assist Devices, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 61
Figure 20: Cardiac Assist Devices, United States, Volume (Units) by Segment, Historic, 2003-2010 63
Figure 21: Cardiac Assist Devices, United States, Volume (Units) by Segment, Forecast, 2010-2017 65
Figure 22: Intra-Aortic Balloon Pumps, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 67
Figure 23: Intra-Aortic Balloon Pumps, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 69
Figure 24: Ventricular Assist Devices, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 71
Figure 25: Ventricular Assist Devices, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 73
Figure 26: Cardiac Assist Devices, United States, Company Share (%), 2010 78
Figure 27: Cardiac Rhythm Management, Market Segmentation 80
Figure 28: Cardiac Rhythm Management Market, United States, Revenue Mix ($m), 2010 81
Figure 29: Cardiac Rhythm Management Market, United States, Segment Contribution (%), 2010 82
Figure 30: Cardiac Rhythm Management, United States, Revenue ($m) by Segment, Historic, 2003-2010 83
Figure 31: Cardiac Rhythm Management, United States, Revenue ($m) by Segment, Forecast, 2010-2017 85
Figure 32: Cardiac Resynchronisation Therapy, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 87
Figure 33: Cardiac Resynchronisation Therapy, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 89
Figure 34: Implantable Cardioverter Defibrillators, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 91
Figure 35: Implantable Cardioverter Defibrillators, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 93
Figure 36: Pacemakers, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 95
Figure 37: Pacemakers, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 97
Figure 38: Cardiac Rhythm Management, United States, Volume (Units) by Segment, Historic, 2003-2010 99
Figure 39: Cardiac Rhythm Management, United States, Volume (Units) by Segment, Forecast, 2010-2017 101
Figure 40: Cardiac Resynchronisation Therapy, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 103
Figure 41: Cardiac Resynchronisation Therapy, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 105
Figure 42: Implantable Cardioverter Defibrillators, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 107
Figure 43: Implantable Cardioverter Defibrillators, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 109
Figure 44: Pacemakers, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 111
Figure 45: Pacemakers, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 113
Figure 46: Cardiac Rhythm Management, United States, Company Share (%), 2010 116
Figure 47: Cardiovascular Monitoring and Diagnostic Devices, Market Segmentation 118
Figure 48: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Revenue Mix ($m), 2010 119
Figure 49: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Segment Contribution (%), 2010 120
Figure 50: Cardiovascular Monitoring and Diagnostic Devices, United States, Revenue ($m) by Segment, Historic, 2003-2010 121
Figure 51: Cardiovascular Monitoring and Diagnostic Devices, United States, Revenue ($m) by Segment, Forecast, 2010-2017 123
Figure 52: Cardiovascular Monitoring and Diagnostic Devices, United States, Volume (Units) by Segment, Historic, 2003-2010 125
Figure 53: Cardiovascular Monitoring and Diagnostic Devices, United States, Volume (Units) by Segment, Forecast, 2010-2017 127
Figure 54: Cardiovascular Monitoring and Diagnostic Devices, United States, Company Share (%), 2010 132
Figure 55: Cardiovascular Prosthetic Devices, Market Segmentation 134
Figure 56: Cardiovascular Prosthetic Devices Market, United States, Revenue Mix ($m), 2010 135
Figure 57: Cardiovascular Prosthetic Devices Market, United States, Segment Contribution (%), 2010 136
Figure 58: Cardiovascular Prosthetic Devices, United States, Revenue ($m) by Segment, Historic, 2003-2010 137
Figure 59: Cardiovascular Prosthetic Devices, United States, Revenue ($m) by Segment, Forecast, 2010-2017 139
Figure 60: Septal Occluders, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 141
Figure 61: Septal Occluders, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 143
Figure 62: Cardiovascular Prosthetic Devices, United States, Volume (Units) by Segment, Historic, 2003-2010 145
Figure 63: Cardiovascular Prosthetic Devices, United States, Volume (Units) by Segment, Forecast, 2010-2017 147
Figure 64: Septal Occluders, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 149
Figure 65: Septal Occluders, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 151
Figure 66: Cardiovascular Prosthetic Devices, United States, Company Share (%), 2010 155
Figure 67: Cardiovascular Surgery, Market Segmentation 157
Figure 68: Cardiovascular Surgery Market, United States, Revenue Mix ($m), 2010 158
Figure 69: Cardiovascular Surgery Market, United States, Segment Contribution (%), 2010 159
Figure 70: Cardiovascular Surgery, United States, Revenue ($m) by Segment, Historic, 2003-2010 160
Figure 71: Cardiovascular Surgery, United States, Revenue ($m) by Segment, Forecast, 2010-2017 162
Figure 72: Beating Heart Surgery Systems, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 164
Figure 73: Beating Heart Surgery Systems, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 166
Figure 74: Perfusion Disposables, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 168
Figure 75: Perfusion Disposables, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 170
Figure 76: Cardiovascular Surgery, United States, Volume (Units) by Segment, Historic, 2003-2010 172
Figure 77: Cardiovascular Surgery, United States, Volume (Units) by Segment, Forecast, 2010-2017 174
Figure 78: Beating Heart Surgery Systems, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 176
Figure 79: Beating Heart Surgery Systems, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 178
Figure 80: Perfusion Disposables, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 180
Figure 81: Perfusion Disposables, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 182
Figure 82: Cardiovascular Surgery, United States, Company Share (%), 2010 186
Figure 83: Electrophysiology, Market Segmentation 188
Figure 84: Electrophysiology Market, United States, Revenue Mix ($m), 2010 189
Figure 85: Electrophysiology Market, United States, Segment Contribution (%), 2010 190
Figure 86: Electrophysiology, United States, Revenue ($m) by Segment, Historic, 2003-2010 191
Figure 87: Electrophysiology, United States, Revenue ($m) by Segment, Forecast, 2010-2017 193
Figure 88: Electrophysiology, United States, Volume (Units) by Segment, Historic, 2003-2010 195
Figure 89: Electrophysiology, United States, Volume (Units) by Segment, Forecast, 2010-2017 197
Figure 90: Electrophysiology, United States, Company Share (%), 2010 201
Figure 91: External Defibrillators, Market Segmentation 203
Figure 92: External Defibrillators Market, United States, Revenue Mix ($m), 2010 204
Figure 93: External Defibrillators Market, United States, Segment Contribution (%), 2010 205
Figure 94: External Defibrillators, United States, Revenue ($m) by Segment, Historic, 2003-2010 206
Figure 95: External Defibrillators, United States, Revenue ($m) by Segment, Forecast, 2010-2017 208
Figure 96: External Defibrillators, United States, Volume (Units) by Segment, Historic, 2003-2010 210
Figure 97: External Defibrillators, United States, Volume (Units) by Segment, Forecast, 2010-2017 212
Figure 98: External Defibrillators, United States, Company Share (%), 2010 216
Figure 99: Interventional Cardiology, Market Segmentation 217
Figure 100: Interventional Cardiology Market, United States, Revenue Mix ($m), 2010 218
Figure 101: Interventional Cardiology Market, United States, Segment Contribution (%), 2010 219
Figure 102: Interventional Cardiology, United States, Revenue ($m) by Segment, Historic, 2003-2010 220
Figure 103: Interventional Cardiology, United States, Revenue ($m) by Segment, Forecast, 2010-2017 222
Figure 104: Cardiac Catheters, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 224
Figure 105: Cardiac Catheters, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 226
Figure 106: Coronary Stents, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 228
Figure 107: Coronary Stents, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 230
Figure 108: PTCA Balloons, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 232
Figure 109: PTCA Balloons, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 234
Figure 110: Intravascular Ultrasound Systems (IVUS), United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 236
Figure 111: Intravascular Ultrasound Systems (IVUS), United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 238
Figure 112: Interventional Cardiology, United States, Volume (Units) by Segment, Historic, 2003-2010 240
Figure 113: Interventional Cardiology, United States, Volume (Units) by Segment, Forecast, 2010-2017 242
Figure 114: Cardiac Catheters, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 244
Figure 115: Cardiac Catheters, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 246
Figure 116: Coronary Stents, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 247
Figure 117: Coronary Stents, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 249
Figure 118: PTCA Balloons, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 250
Figure 119: PTCA Balloons, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 252
Figure 120: Intravascular Ultrasound Systems (IVUS), United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 254
Figure 121: Intravascular Ultrasound Systems (IVUS), United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 256
Figure 122: Interventional Cardiology, United States, Company Share (%), 2010 261
Figure 123: Cardiac Catheters, United States, Company Share (%), 2010 263
Figure 124: Coronary Stents, United States, Company Share (%), 2010 264
Figure 125: Peripheral Vascular Devices, Market Segmentation 265
Figure 126: Peripheral Vascular Devices Market, United States, Revenue Mix ($m), 2010 266
Figure 127: Peripheral Vascular Devices Market, United States, Segment Contribution (%), 2010 267
Figure 128: Peripheral Vascular Devices, United States, Revenue ($m) by Segment, Historic, 2003-2010 268
Figure 129: Peripheral Vascular Devices, United States, Revenue ($m) by Segment, Forecast, 2010-2017 270
Figure 130: Stent Grafts, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 272
Figure 131: Stent Grafts, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 274
Figure 132: Inferior Vena Cava Filters (IVCF), United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 276
Figure 133: Inferior Vena Cava Filters (IVCF), United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 278
Figure 134: Peripheral Vascular Stents, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 280
Figure 135: Peripheral Vascular Stents, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 282
Figure 136: Peripheral Vascular Devices, United States, Volume (Units) by Segment, Historic, 2003-2010 284
Figure 137: Peripheral Vascular Devices, United States, Volume (Units) by Segment, Forecast, 2010-2017 286
Figure 138: Stent Grafts, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 288
Figure 139: Stent Grafts, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 290
Figure 140: Inferior Vena Cava Filters (IVCF), United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 291
Figure 141: Inferior Vena Cava Filters (IVCF), United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 293
Figure 142: Peripheral Vascular Stents, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 295
Figure 143: Peripheral Vascular Stents, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 297
Figure 144: Peripheral Vascular Devices, United States, Company Share (%), 2010 302
Figure 145: Prosthetic Heart Valves, Market Segmentation 304
Figure 146: Prosthetic Heart Valves Market, United States, Revenue Mix ($m), 2010 305
Figure 147: Prosthetic Heart Valves Market, United States, Segment Contribution (%), 2010 306
Figure 148: Prosthetic Heart Valves, United States, Revenue ($m) by Segment, Historic, 2003-2010 307
Figure 149: Prosthetic Heart Valves, United States, Revenue ($m) by Segment, Forecast, 2010-2017 309
Figure 150: Mechanical Heart Valves, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 310
Figure 151: Mechanical Heart Valves, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 312
Figure 152: Tissue Heart Valves, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 314
Figure 153: Tissue Heart Valves, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 316
Figure 154: Prosthetic Heart Valves, United States, Volume (Units) by Segment, Historic, 2003-2010 318
Figure 155: Prosthetic Heart Valves, United States, Volume (Units) by Segment, Forecast, 2010-2017 319
Figure 156: Mechanical Heart Valves, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 320
Figure 157: Mechanical Heart Valves, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 322
Figure 158: Tissue Heart Valves, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 324
Figure 159: Tissue Heart Valves, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 326
Figure 160: Prosthetic Heart Valves, United States, Company Share (%), 2010 330
Figure 161: Medtronic, Inc., Company Share (%),United States Cardiovascular Devices Market, 2010 332
Figure 162: Boston Scientific Corporation, Company Share (%),United States Cardiovascular Devices Market, 2010 333
Figure 163: St. Jude Medical, Inc., Company Share (%),United States Cardiovascular Devices Market, 2010 334
Figure 164: Abbott Laboratories, Company Share (%),United States Cardiovascular Devices Market, 2010 335
Figure 165: Cordis Corporation, Company Share (%),United States Cardiovascular Devices Market, 2010 336
Figure 166: C. R. Bard, Inc., Company Share (%),United States Cardiovascular Devices Market, 2010 337

Upcoming Reports:

Smart Glass Market - Global Industry Analysis, Market Size, Share, Growth, Trends, and Forecast, 2012 - 2018
By - Transparency Market Research
Smart glass is also known as magic glass or switchable glass and has a wide range of applications in residential, commercial, architectural, and automotive industries. Smart glasses are used as sun roof tops (to control the amount of sunlight) and in rear view mirrors in vehicles. Smart glass technology includes suspended particle devices, liquid crystal devices, electrochromic devices, and micro-blinds.  The smart glass market is registering a healthy growth rate due to the growing automotive market. Eco-friendly and green buildings and non-electric technologies...
Lighting Equipment Market - Global Industry Analysis, Size, Share, Growth, Trends, And Forecast, 2012 - 2018
By - Transparency Market Research
Lighting equipment could be mundanely understood as the equipment responsible for the production of light energy. With an ever increasing rise in the global population, and the rising awareness amongst us to protect our mother earth, lighting equipment market is experiencing a healthy growth rate. Rising global population, rising urbanization rate, invention of innovative products such as LED, rising go green initiatives, are some of the drivers of the lighting equipment market. The rising economies of the Asia Pacific countries, will serve as an opportunity for the lighting...
Microwave Ovens Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts 2012 - 2018
By - Transparency Market Research
The global microwave oven market is projected to grow to $72.5 million by the year 2015 mainly driven by the replacement demand, niche product development and re-establishment of old product line in developed markets of America and Europe. Increasing income levels and growing living standards are influencing the growth of this market across the developing markets of Asia and Eastern Europe. Due to the increasing need of luxury gadgets, microwave ovens are becoming an essential part of modern and well furnished kitchen. Number of technological developments and improvements in design...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Select License type:

Share this report

Related News

One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012  
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012  
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples. The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012  
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
Battling against flu, vaccination necessary for health workers
Sep 14, 2012  
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease. Health officials...
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012  
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...